Drugs Versus Microbiota: How Pharmacotherapy Affects Gut and Probiotic Bacteria

Area of Science:

• Microbiology
• Pharmacology
• Human Health

Background:

• The gut microbiota is crucial for digestion, immunity, and metabolism.
• Medications for diabetes, hypothyroidism, cardiovascular disease, and acid reflux can disrupt gut microbiota balance, causing dysbiosis.
• Dysbiosis is linked to various health problems.

Purpose of the Study:

• To investigate the long-term effects of specific pharmaceuticals on gut and probiotic microbiota.
• To determine if probiotic supplementation is a viable strategy for patients using these medications.

Main Methods:

• Review of existing literature on pharmaceutical impact on gut microbiota.
• Analysis of studies examining probiotic interventions in patients on long-term medication.

Main Results:

• Certain common medications significantly alter gut microbiota composition.
• These alterations can negatively impact host health and metabolic processes.
• Probiotic supplementation may help restore microbial balance in some cases.

Conclusions:

• Long-term pharmaceutical use necessitates consideration of gut microbiota health.
• Probiotics show potential as a therapeutic adjunct for managing drug-induced dysbiosis.
• Further research is needed to establish specific probiotic recommendations.